RTOG 0529: Intensity modulated radiation therapy and anal cancer, a step in the right direction?

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 1, 2013, Pages 8-10

  Herman, Joseph M ^a   Thomas, Charles R ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; MITOMYCIN; OXALIPLATIN;

ANUS CANCER; BIOPSY; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; COLOSTOMY; DISEASE FREE SURVIVAL; DOSIMETRY; DRUG EFFICACY; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FRACTIONATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; METABOLIC DISORDER; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE ESCALATION; RADIOSENSITIZATION; RECTUM CANCER; REVIEW; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; TOXICITY; TREATMENT FAILURE; TREATMENT PLANNING; UROGENITAL TRACT DISEASE;

EID: 84876023233     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.01.034     Document Type: Editorial

References (27)

1. E. Chan, L.A. Kachnic, and C.R. Thomas Jr. Anal cancer: Progress on combined-modality and organ preservation Curr Probl Cancer 33 2009 302 326
2. A.B. Benson 3rd, J.P. Arnoletti, and T. Bekaii-Saab Anal carcinoma, version 2.2012: Featured updates to the NCCN guidelines J Natl Compr Canc Netw 10 2012 449 454
3. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial JAMA 299 2008 1914 1921 (Pubitemid 351574921)
4. L.L. Gunderson, K.A. Winter, and J.A. Ajani Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/ mitomycin versus fluorouracil/cisplatin J Clin Oncol 30 2012 4344 4351
5. J.J. Meyer, C.G. Willett, and B.G. Czito Emerging role of intensity-modulated radiation therapy in anorectal cancer Expert Rev Anticancer Ther 8 2008 585 593 (Pubitemid 351818353)
6. J.M. Herman, and C.R. Thomas Jr. Intensity-modulated radiation therapy for anal cancer: An obvious yet complicated transition Oncology (Williston Park) 24 2010 828, 830 831
7. C. Menkarios, D. Azria, and B. Laliberté Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: A comparison of conventional and IMRT plans Radiat Oncol 2 2007 41
8. J.G. Bazan, W. Hara, and A. Hsu Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal Cancer 117 2011 3342 3351
9. J.M. Pepek, C.G. Willett, and Q.J. Wu Intensity-modulated radiation therapy for anal malignancies: A preliminary toxicity and disease outcomes analysis Int J Radiat Oncol Biol Phys 78 2010 1413 1419
10. L.A. Kachnic, K. Winter, and R.J. Myerson RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 86 2013 27 33
11. R.J. Myerson, M.C. Garofalo, and I. El Naqa Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas Int J Radiat Oncol Biol Phys 74 2009 824 830
12. J.M. Herman Proton therapy in an era of cost containment J Natl Compr Canc Netw 9 2011 821 825
13. J.D. Murphy, D.T. Chang, and J. Abelson Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer Cancer 118 2012 1119 1129
14. A.C. Hartford, J.M. Galvin, and D.C. Beyer American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for intensity-modulated radiation therapy (IMRT) Am J Clin Oncol 35 2012 612 617
15. S.R. Smalley, J.K. Benedetti, and D.G. Haller Updated analysis of SWOG-directed intergroup study 0116: A phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection J Clin Oncol 30 2012 2327 2333
16. W.F. Regine, K.A. Winter, and R. Abrams Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial Ann Surg Oncol 18 2011 1319 1326
17. H.A. Gay, H.J. Barthold, and E. O'Meara Pelvic normal tissue contouring guidelines for radiation therapy: A radiation therapy oncology group consensus panel atlas Int J Radiat Oncol Biol Phys 83 2012 e353 e362
18. M. Ng, T. Leong, and S. Chander Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer Int J Radiat Oncol Biol Phys 83 2012 1455 1462
19. C.D. Fuller, J. Nijkamp, and J.C. Duppen Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting Int J Radiat Oncol Biol Phys 79 2011 481 489
20. J.P. Chino, W.R. Lee, and R. Madden Teaching the anatomy of oncology: Evaluating the impact of a dedicated oncoanatomy course Int J Radiat Oncol Biol Phys 79 2011 853 859
21. J.E. Bekelman, S. Wolden, and N. Lee Head-and-neck target delineation among radiation oncology residents after a teaching intervention: A prospective, blinded pilot study Int J Radiat Oncol Biol Phys 73 2009 416 423
22. Y.J. Chen, S. Suh, and R.A. Nelson Setup variations in radiotherapy of anal cancer: Advantages of target volume reduction using image-guided radiation treatment Int J Radiat Oncol Biol Phys 84 2012 289 295
23. S.J. Wong, K. Winter, and N.J. Meropol Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer Int J Radiat Oncol Biol Phys 82 2012 1367 1375
24. K. Blackwell, H. Hurwitz, and G. Lieberman Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma Cancer 101 2004 77 82 (Pubitemid 38812425)
25. C.F. Snyder, A.L. Blackford, and A.C. Wolff Feasibility and value of PatientViewpoint: A web system for patient-reported outcomes assessment in clinical practice Psychooncology 2012 Apr 30 10.1002/pon.3087 [Epub ahead of print].
26. L.A. Kachnic, K. Winter, and T. Wasserman Longitudinal quality-of-life analysis of RTOG 94-05 (int 0123): A phase III trial of definitive chemoradiotherapy for esophageal cancer Gastrointest Cancer Res 4 2011 45 52
27. A.H. Ko, and D. Cella Achieving the best of both worlds J Clin Oncol 31 2013 3